Dot Your I’s and Check Your Deeds Before Celebrating 4/20

by Pillsbury - Gravel2Gavel Construction & Real Estate Law

The cannabis industry – both recreational and medicinal – is one of constant development, with a litany of obstacles.  Even since December of last year when we began our series on the legalization of marijuana and its correlation to the real estate industry, new wrinkles have emerged, which may have an effect on future cannabis real estate deals.

In 2017, PharmaCann, an Illinois-based medical marijuana grower and retailer, purchased a property located just outside the Philadelphia Mills shopping center, where it planned to build a medical marijuana dispensary.  The company obtained a state permit and city approval to operate a dispensary on the property, however, the owner of the shopping center claimed that the deed to the property prohibited the site from being used as a “drug store” or for any “unlawful” purpose.  PharmaCann filed a complaint in Pennsylvania state court, asking the court to interpret the deed and to approve the opening of its dispensary.  PharmaCann argued that because the sale of medical marijuana in Pennsylvania is only permitted in the form of highly-concentrated oils and resins, it is not like a typical drugstore such as CVS or Walgreens and that that the restriction on unlawful use was inapplicable since the product PharmaCann would be selling is legal under Pennsylvania law.  In October of last year, the property owner subsequently removed the case to federal court.  In March of this year, the U.S. District Judge Gene Pratter ultimately found that federal question jurisdiction exists, and as such, the case can be heard in federal court.  In reaching this decision, Pratter opined that the case turns on whether the proposed store is “unlawful” which “tee[s] up a fundamental clash between state and federal law” thus opening the door for federal question jurisdiction.

Currently, 94% of Americans support the legalization of marijuana, while 61% support the legalization of recreational marijuana.  However, despite this wide support, the legal climate surrounding cannabis continues to be unstable as the battle between state and federal law escalates.  As we discussed in Part 2, while cannabis is legal in 30 different states, it continues to be classified as an illegal drug under the federal Controlled Substances Act (“CSA”), which has resulted in cannabis legal feuds across the country.  In February of this year, a federal judge rejected a lawsuit which sought to legalize marijuana under federal law, explaining that although marijuana indeed has a clear, medical purpose, it is the responsibility of Congress and the Drug Enforcement Administration to declassify it as a Schedule I drug.  In March of this year, a Bankruptcy Appellate Panel for the 9th Circuit remanded a Chapter 13 case against a landlord who leased a space to a state-licensed marijuana dispensary, finding that a court cannot rely solely on the CSA to dismiss a case without first articulating a cause for dismissal.  Such a finding means that in the future, bankruptcy courts will have to make substantive factual and legal findings in order to dismiss marijuana cases.  Concurring in the opinion, Judge Maureen Tighe noted that the expansion of the marijuana industry across state lines requires courts to take into account a debtor’s compliance with state law.  Recently, a California court decided a case with similar facts as the PharmaCann case.  On April 1, 2018, the California judge ordered that marijuana be permitted at the Coachella Valley Music and Arts Festival due to the property deed permitting a wide variety of uses, so long as such uses are permitted by the laws of California.

A ruling against PharmaCann in federal court could have a national effect due to the Supremacy Clause likely “cast[ing] doubt on the validity of dozens of state marijuana schemes.”  Because the PharmaCann case hinges on the federal court deciding whether the operation of a medical marijuana dispensary is “unlawful”, a decision against PharmaCann offers support for a prohibition on commercial, marijuana activity, by derailing dispensary operations located on a property with similar deed language.  Additionally, such a ruling “could allow any landlord to evict any tenant involved in the cannabis industry by taking them to federal court.”  Even obscure legal opinions could be leveraged to undo a real estate deal.  Due to these potential, far-reaching ramifications, PharmaCann is carefully weighing its options – appeal, proceed with the case in federal court, or withdraw its plans to build on the property altogether, which could render the case moot.

PharmaCann argues that a decision on the legality of state medical marijuana statutes should be left to the states.  In making this argument, PharmaCann cites to the shifting political view of marijuana, medicinal benefits of using marijuana, and the lack of federal enforcement of marijuana laws against state-regulated medical marijuana businesses.  Although Judge Pratter rejected these arguments as irrelevant to the issue of whether federal jurisdiction exists, she left a word of caution on how a decision on the merits of this case could come out – “It is not this Court’s role to second-guess the political wisdom of the federal legislation on marijuana.”

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pillsbury - Gravel2Gavel Construction & Real Estate Law | Attorney Advertising

Written by:

Pillsbury - Gravel2Gavel Construction & Real Estate Law

Pillsbury - Gravel2Gavel Construction & Real Estate Law on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.